Octreotide
Synthetic somatostatin analogue sold as Sandostatin. Suppresses GH, IGF-1, glucagon, and insulin; used clinically for acromegaly, carcinoid syndrome, and GH management.
0 anonymous reports
Also known as:
sandostatinsandostatin larsms 201-995
community guides:
No reports found.
Community Q&A
- What is octreotide used for in the peptide community?
- Community accounts describe octreotide in two distinct contexts. Acromegaly management accounts come from users with diagnosed GH excess needing pharmaceutical suppression. Bodybuilding accounts describe using octreotide specifically to reduce IGF-1 during post-cycle periods or to modulate gut distension ('HGH gut') from chronic growth factor elevation. The latter context is controversial in confessions — accounts split on whether the gut reduction effect is attributable to octreotide or other protocol changes.
- Does octreotide reduce IGF-1 levels?
- Community accounts consistently confirm octreotide's IGF-1 lowering effect — citing it as both an intended outcome (in acromegaly management) and a side effect concern (in growth protocol users who rely on IGF-1 elevation). Accounts describe rapid IGF-1 reduction within days of starting octreotide. The implication for GH secretagogue users: octreotide would counteract the benefits of compounds like CJC-1295, ipamorelin, and MK-677. Most bodybuilding accounts describe very short, targeted octreotide use rather than continuous administration.